Atlas Trials

NSCLC, Stage III

28 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch NSCLC, Stage III

RecordFirmDate
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities (NCT05311709)Vestre Viken Hospital Trust2022-05-30
SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC (NCT05177497)Shanghai Chest Hospital2022-01-01
Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC. (NCT05128630)Fondazione IRCCS Policlinico San Matteo di Pavia2021-10-28
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC (NCT04585490)Maximilian Diehn2021-08-25
Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC (NCT04952168)Yuan Chen2021-06-02
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients (NCT04680377)Jun Zhang, MD, PhD2021-04-12
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (NCT05027165)LMU Klinikum2020-11-07
Lung Cancer Registry (NCT04654364)Arbeitsgemeinschaft medikamentoese Tumortherapie2020-08-18
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China (NCT04830826)The First Affiliated Hospital of Guangzhou Medical University2020-07-09
Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (NCT04351256)Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2020-05-20
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study (NCT04392505)Oslo University Hospital2020-05-11
Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC. (NCT04202809)University Hospital, Essen2020-01-13
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer (NCT03999710)Memorial Sloan Kettering Cancer Center2019-07-19
The Role of Microbiota on the Development of Lung Cancer (NCT03454685)Xiaorong Dong2018-01-30
To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC (NCT03130829)Hi-Q Marine Biotech International, Ltd.2017-04-26

Track NSCLC, Stage III automatically

Every clearance here is in the API, with alerts when new ones post.